Landiolol Clinical Trials
4 recruitingDrug
Phase 42Phase 32
Showing 1–4 of 4 trials
Recruiting
Phase 4
LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery
myocardial injury after non-cardiac surgeryAutonomic DysfunctionCardiovascular (CV) Risk+3 more
Insel Gruppe AG, University Hospital Bern114 enrolled1 locationNCT07168421
Recruiting
Phase 4
Landiolol in Mitral Valve Surgery
Cardiac FailureLow Cardiac Output Syndrome
Università Vita-Salute San Raffaele1,500 enrolled13 locationsNCT06793670
Recruiting
Phase 3
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility
Septic ShockTachycardiaMortality During Septic Shock+1 more
Centre Hospitalier Universitaire, Amiens360 enrolled1 locationNCT04748796
Recruiting
Phase 3
LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)
Septic Shock
Assistance Publique - Hôpitaux de Paris44 enrolled1 locationNCT04931225